Pyridoindole SMe1EC2 as cognition enhancer in ageing-related cognitive decline

摘要

Synthetic pyridoindole-type substances derived from the lead compound stobadine represent promising agents in treatment of a range of pathologies including neurological disorders. The beneficial biological effects were suggested to be likely associated with their capacity to ameliorate oxidative damage.